Lawrence Thomas R 4
4 · CUMBERLAND PHARMACEUTICALS INC · Filed Nov 16, 2012
Insider Transaction Report
Form 4
Lawrence Thomas R
Director
Transactions
- Exercise/Conversion
Common stock
2012-11-16$3.50/sh+8,000$28,000→ 197,576 total - Sale
common stock
2012-11-16$4.45/sh−6,222$27,688→ 191,354 total - Exercise/Conversion
Options
2012-11-16−8,000→ 0 totalExercise: $3.50From: 2003-01-31Exp: 2013-01-31→ Common stock (8,000 underlying)
Footnotes (1)
- [F1]Shares sold to Cumberland Pharmaceuticals Inc. to satisfy the exercise price of the options exercised on 11/16/2012.